Yıl: 2022 Cilt: 28 Sayı: 1 Sayfa Aralığı: 14 - 18 Metin Dili: Türkçe DOI: 10.4274/tnd.2021.17992 İndeks Tarihi: 22-05-2023

Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi

Öz:
Amaç: İskemik inme rekürrensi (İİR), İİ hastanın karşı karşıya olduğu büyük bir tehdittir. Minör İİ’si (Mİİ) olan hastalarda İİR riski ilk 3 ayda %10-13’tür. Hastaların ileri tetkik ve tedavisine rağmen, İİR hala sıktır. Hangi risk faktörlerinin İİR’ye sebep olduğunu bilmek bazı önlemlerin alınması açısından önemlidir. Bu çalışmanın amacı Mİİ’li hastalarda İİR ile ilişkili demografik, klinik ve radyolojik özelliklerin saptanarak riskli grubun belirlenmesidir. Gereç ve Yöntem: Bu çalışmaya 01.01.2019-01.01.2020 tarihleri arasında Bursa Uludağ Üniversitesi Tıp Fakültesi Nöroloji Anabilim Dalı tarafından akut İİ (Aİİ) tanısı konulan 310 hasta retrospektif olarak taranarak dahil edildi. Bulgular: İR’si olan ve olmayan hastalarda klinik, radyolojik ve demografik özellikler analiz edildiğinde; koroner arter hastalığı (KAH) varlığı, aterosklerotik damar hastalığı, anterior sirkülasyon inmesi, kraniyoservikal aterosklerotik stenoz, anterior sirkülasyonda aterosklerotik stenoz, semptomatik internal karotid arterde aterosklerotik stenoz, asemptomatik internal karotis arterde (İCA) aterosklerotik stenoz ve karotis arter stentleme işleminin yapılması açısından istatistiksel olarak anlamlı farklılıklar saptandı. Mİİ’li hastalarda anlamlı değişkenler binary logistik regresyon ile analiz edildiğinde en anlamlı değişkenlerin KAH ve asemptomatik İCA stenozu olduğu saptandı. Sonuç: Çalışmamızda Mİİ’li hastalarda İİR ile en ilişkili risk faktörleri KAH varlığı ve asemptomatik İCA stenozu olarak saptanmıştır. Ateroskleroz sistemik bir hastalıktır ve bu sebeble kraniyoservikal aterosklerotik stenoz multipl olabilir. Anjiyografik kanıtlar Aİİ’li hastalarda etnik ve ırksal farklılıkları da ortaya koymuştur. Bu sebeple kendi popülasyonumuzda yapılacak prospektif çalışmalarla daha kesin bilgilere ulaşılabilir.
Anahtar Kelime:

Evaluation of Risk Factors Associated with Stroke Recurrence in Patients with Minor Ischemic Stroke

Öz:
Objective: Recurrent ischemic stroke (RIS) is a major threat to patients with IS. The risk of RIS in patients with minor IS (MIS) is 10-13% in the first 3 months. Despite the advanced examination and treatment of the patients, RIS is still common. It is important to know which risk factors cause RIS in order to take some precautions. The aim of this study is to determine the risky group by determining the demographic, clinical and radiological features associated with RIS in patients with MIS. Materials and Methods: We included 310 patients diagnosed as having acute IS (AIS) by Bursa Uludag University Faculty of Medicine Department of Neurology between 01.01.2019 and 01.01.2020, retrospectively. Results: When clinical, radiological and dermogrophic features were analyzed between patients with and without RIS, there were statistically significant differences between groups in terms of the presence of coronary artery disease (CAD), atherosclerotic vascular disease, anterior circulation stroke, craniocervical atherosclerotic stenosis, atherosclerotic stenosis in the anterior circulation, atherosclerotic stenosis of the symptomatic internal carotid artery (ICA), atherosclerotic stenosis in the asymptomatic ICA and performing carotid artery stenting. When significant variables were analyzed by using binary logistic regression in patients with MIS, it was found that the most significant variables were CAD and asymptomatic ICA stenosis. Conclusion: In our study, the risk factors associated with RIS in patients with MIS were the presence of CAD and asymptomatic ICA stenosis. Atherosclerosis is a systemic disease and therefore craniocervical atherosclerotic stenosis may be multiple. Angiographic evidence has also revealed ethnic and racial differences in patients with AIS. For this reason, more precise information can be obtained with prospective studies to be conducted in our own population.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Oza R, Rundell K, Garcellano M. Recurrent ischemic stroke: strategies for prevention. Am Fam Physician 2017;96:436-440.
  • 2. Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013;369:11-19.
  • 3. Daubail B, Durier J, Jacquin A, et al. Factors associated with early recurrence at the first evaluation of patients with transient ischemic attack. J Clin Neurosci 2014;21:1940-1944.
  • 4. Fischer U, Baumgartner A, Arnold M, et al. What is a minor stroke? Stroke 2010;41:661-666.
  • 5. Dhamoon MS, Moon YP, Paik MC, et al. Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke 2009;40:2805- 2811.
  • 6. Reeves M, Khoury J, Alwell K, et al. Distribution of national institutes of health stroke scale in the Cincinnati/Northern Kentucky stroke study. Stroke 2013;44:3211-3213.
  • 7. Arsava EM, Kim GM, Oliveira-Filho J, et al. Prediction of early recurrence after acute ischemic stroke. JAMA Neurol 2016;73:396-401.
  • 8. Kang DW, Yoo SH, Chun S, et al. Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. Stroke 2009;40:1653-1658.
  • 9. Lee M, Wu YL, Ovbiagele B. Trends in incident and recurrent rates of first-ever ischemic stroke in Taiwan between 2000 and 2011. J Stroke 2016;18:60-65.
  • 10. Bergström L, Irewall AL, Söderström L, et al. One-year incidence, time trends, and predictors of recurrent ischemic stroke in Sweden from 1998 to 2010: an observational study. Stroke 2017;48:2046-2051.
  • 11. Kumral E, Topcuoglu MA, Onal MZ. Anterior circulation syndromes. Handb Clin Neurol 2009;93:485-536.
  • 12. Easton DJ, Fauci AS, Isselbacher KJ. Cerebrovascular disease. In: Anonymous Harrison’s Principle of Internal Medicine. Fauci AS, Longo D, Kasper DL, Wilson JD, Martin JB, eds. New York: McGraw Hill, 1998:2325-2348.
  • 13. Khatri P, Conaway MR, Johnston KC; Acute Stroke Accurate Prediction Study (ASAP) Investigators. Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke. Stroke 2012;43:560-562.
  • 14. Amarenco P, Labreuche J, Lavallée PC, et al. Does ABCD2 score below 4 allow more time to evaluate patients with a transient ischemic attack? Stroke 2009;40:3091-3095.
  • 15. Josephson SA, Sidney S, Pham TN, Bernstein AL, Johnston SC. Higher ABCD2 score predicts patients most likely to have true transient ischemic attack. Stroke 2008;39:3096-3098.
  • 16. Purroy F, Jiménez-Caballero PE, Mauri-Capdevila G, et al. PROMAPA study: stroke project, cerebrovascular diseases study group, Spanish neurological society. Predictive value of brain and vascular imaging including intracranial vessels in transient ischaemic attack patients: external validation of the ABCD3-I score. Eur J Neurol 2013;20:1088-1093.
  • 17. Kiyohara T, Kamouchi M, Kumai Y, et al. ABCD3 and ABCD3-I scores are superior to ABCD2 score in the prediction of short- and long-term risks of stroke after transient ischemic attack. Stroke 2014;45:418-425.
  • 18. Wardlaw JM, Brazzelli M, Chappell FM, et al. ABCD2 score and secondary stroke prevention: meta-analysis and effect per 1,000 patients triaged. Neurology 2015;85:373-380.
  • 19. Purroy F, Jiménez Caballero PE, Gorospe A, et al. Stroke Project of the Spanish cerebrovascular diseases study group. Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores. Cerebrovasc Dis 2012;33:182-189.
  • 20. Purroy F, Montaner J, Molina CA, et al. Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke 2007;38:3225-3229.
  • 21. Smith EE, Fonarow GC, Reeves MJ, et al. Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from get with the guidelines-stroke. Stroke 2011;42:3110-3115.
  • 22. Willey JZ, Stillman J, Rivolta JA, et al. Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms. Int J Stroke 2012;7:202-206.
  • 23. Mathur A, Roubin GS, Iyer SS, et al. Predictors of stroke complicating carotid artery stenting. Circulation 1998;97:1239-1245.
  • 24. Diehm N, Katzen BT, Iyer SS, et al. Staged bilateral carotid stenting, an effective strategy in high-risk patients - insights from a prospective multicenter trial. J Vasc Surg 2008;47:1227-1234.
  • 25. Roubin GS, New G, Iyer SS, et al. Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 2001;103:532-537.
  • 26. White CJ, Iyer SS, Hopkins LN, et al. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv 2006;67:503-512.
  • 27. Naylor AR. Delay may reduce procedural risk, but at what price to the patient? Eur J Vasc Endovasc Surg 2008;35:383-391.
  • 28. Liu S, Jung JH, Kim SM, et al. Simultaneous bilateral carotid stenting in high-risk patients. AJNR Am J Neuroradiol 2010;31:1113-1117.
  • 29. Fujimoto S, Yasaka M, Otsubo R, et al. Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke 2004;35:1426-1429.
  • 30. Ay H. Etiologic classification in ischemic stroke. Turk J Neurol 2011;17:1- 6.
  • 31. Kaithoju S. Ischemic stroke: risk stratification, warfarin treatment and outcome measure. J Atr Fibrillation 2015;8:1144.
  • 32. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883-891.
  • 33. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981-992.
  • 34. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran verus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-1151.
  • 35. Dhamoon MS, Sciacca RR, Rundek T, Sacco RL, Elkind MS. Recurrent stroke and cardiac risks after first ischemic stroke: the Northern Manhattan Study. Neurology 2006;66:641-646.
  • 36. Prosser J, MacGregor L, Lees KR, et al. Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke 2007;38:2295-2302.
  • 37. Amarenco P, Lavallée PC, Labreuche J, et al. Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke 2011;42:22-29.
  • 38. Calvet D, Touzé E, Varenne O, et al. Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study. Circulation 2010;121:1623-1629.
  • 39. Amarenco P, Lavallee PC, Labreuche J, et al. Coronary artery disease and risk of major vascular events after cerebral infarction. Stroke 2013;44:1505- 1512.
  • 40. Karaoğlan M. One-year risk of stroke after transient ischemic attack or minor stroke. Turk J Neurol 2017;23:144-145.
APA dinç y, oğuz akarsu e, Hakyemez B, Bakar M (2022). Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. , 14 - 18. 10.4274/tnd.2021.17992
Chicago dinç yasemin,oğuz akarsu emel,Hakyemez Bahattin,Bakar Mustafa Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. (2022): 14 - 18. 10.4274/tnd.2021.17992
MLA dinç yasemin,oğuz akarsu emel,Hakyemez Bahattin,Bakar Mustafa Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. , 2022, ss.14 - 18. 10.4274/tnd.2021.17992
AMA dinç y,oğuz akarsu e,Hakyemez B,Bakar M Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. . 2022; 14 - 18. 10.4274/tnd.2021.17992
Vancouver dinç y,oğuz akarsu e,Hakyemez B,Bakar M Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. . 2022; 14 - 18. 10.4274/tnd.2021.17992
IEEE dinç y,oğuz akarsu e,Hakyemez B,Bakar M "Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi." , ss.14 - 18, 2022. 10.4274/tnd.2021.17992
ISNAD dinç, yasemin vd. "Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi". (2022), 14-18. https://doi.org/10.4274/tnd.2021.17992
APA dinç y, oğuz akarsu e, Hakyemez B, Bakar M (2022). Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. Türk Nöroloji Dergisi, 28(1), 14 - 18. 10.4274/tnd.2021.17992
Chicago dinç yasemin,oğuz akarsu emel,Hakyemez Bahattin,Bakar Mustafa Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. Türk Nöroloji Dergisi 28, no.1 (2022): 14 - 18. 10.4274/tnd.2021.17992
MLA dinç yasemin,oğuz akarsu emel,Hakyemez Bahattin,Bakar Mustafa Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. Türk Nöroloji Dergisi, vol.28, no.1, 2022, ss.14 - 18. 10.4274/tnd.2021.17992
AMA dinç y,oğuz akarsu e,Hakyemez B,Bakar M Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. Türk Nöroloji Dergisi. 2022; 28(1): 14 - 18. 10.4274/tnd.2021.17992
Vancouver dinç y,oğuz akarsu e,Hakyemez B,Bakar M Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi. Türk Nöroloji Dergisi. 2022; 28(1): 14 - 18. 10.4274/tnd.2021.17992
IEEE dinç y,oğuz akarsu e,Hakyemez B,Bakar M "Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi." Türk Nöroloji Dergisi, 28, ss.14 - 18, 2022. 10.4274/tnd.2021.17992
ISNAD dinç, yasemin vd. "Minör İskemik İnmeli Hastalarda İnme Rekürrensi ile İlişkili Risk Faktörlerinin Değerlendirilmesi". Türk Nöroloji Dergisi 28/1 (2022), 14-18. https://doi.org/10.4274/tnd.2021.17992